APA (7th ed.) Citation

Rosell, R., & Manegold, C. (2012). Molecular profiling as an outcome predictor in the galaxy trialtm (nct01348126): A randomized Iib/Iii study of ganetespib (sta-9090) in combination with docetaxel versus docetaxel alone in subjects with stage Iiib/Iv nsclc. Annals of oncology, 23, .

Chicago Style (17th ed.) Citation

Rosell, Rafael, and Christian Manegold. "Molecular Profiling as an Outcome Predictor in the Galaxy Trialtm (nct01348126): A Randomized Iib/Iii Study of Ganetespib (sta-9090) in Combination with Docetaxel Versus Docetaxel Alone in Subjects with Stage Iiib/Iv Nsclc." Annals of Oncology 23 (2012).

MLA (9th ed.) Citation

Rosell, Rafael, and Christian Manegold. "Molecular Profiling as an Outcome Predictor in the Galaxy Trialtm (nct01348126): A Randomized Iib/Iii Study of Ganetespib (sta-9090) in Combination with Docetaxel Versus Docetaxel Alone in Subjects with Stage Iiib/Iv Nsclc." Annals of Oncology, vol. 23, 2012.